Super-Scope for eyes: imaging trial spots hidden clues in blindness
NCT ID NCT04129021
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a high-resolution imaging system to see tiny structures in the eye that routine tools cannot detect. Researchers will scan 1,200 people with various eye conditions and healthy volunteers. The goal is to better understand diseases like glaucoma, diabetes, and retinal degeneration.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could improve how doctors see and understand eye diseases, leading to earlier or more accurate diagnoses.
- What could go wrong
- This is an observational imaging study, not a treatment trial. It may not directly change patient care or outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORNEAL DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
RECRUITINGParis, 75012, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can insulin eye drops quench dry eyes?
- Spinal zaps could reboot breathing after brain injury
- Can brain scans reveal hidden language struggles after stroke?
- Can a few short nights of sleep tip the scales toward high blood pressure?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- A tablet test aims to catch hidden attention and memory problems after stroke